Ennov recognized by Gartner as a RIM and IDMP vendor

Ennov among few RIM / IDMP vendors

Paris, France & Greensboro, USA – September 20th 2016

Ennov announces that it has been listed by Gartner‘s Michael Shanler as a RIM and IDMP vendor in a research note called “Delayed and Confusing IDMP Compliance Requirements Demand Life Science CIOs Pursue a Two-Part Strategy*”.

In this study, Gartner explains that

  • as the deadline for IDMP compliance is delayed, and IDMP regulatory guidance is currently unclear there is a “need for CIOs to implement an agile vendor and resourcing strategy to address uncertainty”.
  • There is a necessity to “Consider the MDM project requirements at the beginning, before going too far with a bolt-on regulatory information management system (RIMS) solution”.

Gartner also identifies 7 RIM vendors with IDMP offers (among which is Ennov).

RIM and IDMP are closely linked. To ensure a smooth path to compliance for its customers, Ennov provides natively integrated RIM and IDMP solutions.

About Gartner

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Ennov

Ennov’s software suite enables Life Science companies to efficiently manage their regulated contents, and comprising Quality, Pharmacovigilance, Regulatory and Clinical content and process management.

Ennov has over 150 Life Science customers in more than 10 countries, including Caligor RX, Ceva, Horiba, Merck, Septodont, Virbac, Innothera, Air Liquide, Alchem, BASF, Charles River, GSK, Linde, Novartis, Supersonic Imagine, Transgene, Debiopharm, Unither. Pharmaceutical, biotech, medical device, cosmetics, specialty chemical and CRO companies trust Ennov’s solutions.

Please visit us at http://en.ennov.com

* Delayed and Confusing IDMP Compliance Requirements Demand Life Science CIOs Pursue a Two-Part Strategy, 2016
Published: 21 January 2016
Analyst: Michael Shanler

Contact

Olivier Pâris, Ennov oparis@ennov.com